Atlas Trials

Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load.

Clinical trial NCT00040157 · TERMINATED

Trial details

NCT number
NCT00040157
Sponsor
Alexion Pharmaceuticals, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV Infections
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.